Collectively, these observations indicate that, despite their similar BMI, obese subjects with low IGF-1 levels are markedly more predisposed to have multiple metabolic abnormalities, such as increased adiposity, inflammation, dyslipidemia and hyperuricemia than subjects in the standard IGF-1 range. The gene discussed is IGF1; the disease is metabolic syndrome.